Pages that link to "Q43446974"
Jump to navigation
Jump to search
The following pages link to Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours (Q43446974):
Displaying 50 items.
- Gastrointestinal cancers in the era of theranostics: Updates and future perspectives (Q26801215) (← links)
- New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy (Q26827785) (← links)
- Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms (Q26853259) (← links)
- Management of patients with hepatic metastases from neuroendocrine tumors (Q27008832) (← links)
- Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours (Q28247667) (← links)
- Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification (Q28551275) (← links)
- The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis. (Q30252003) (← links)
- Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases (Q30445932) (← links)
- Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia (Q30884528) (← links)
- Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution (Q31095566) (← links)
- Real-world study of everolimus in advanced progressive neuroendocrine tumors (Q33417013) (← links)
- Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms (Q33598498) (← links)
- Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival? (Q33658301) (← links)
- Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel (Q33782024) (← links)
- Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours (Q33783119) (← links)
- Duodenal gangliocytic paraganglioma showing lymph node metastasis: a rare case report (Q33870146) (← links)
- Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study (Q33901099) (← links)
- Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. (Q34073712) (← links)
- ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary (Q34248487) (← links)
- Gastric neuroendocrine tumours (Q34306680) (← links)
- The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma (Q34484273) (← links)
- Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT (Q34503869) (← links)
- Bilocal recurrence of a neuroendocrine carcinoma of the small intestine: A case report (Q34768375) (← links)
- Transplantation and surgical strategies in patients with neuroendocrine liver metastases: protocol of four systematic reviews. (Q35074937) (← links)
- Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours (Q35274974) (← links)
- A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report. (Q35284530) (← links)
- Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors (Q35895493) (← links)
- Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis (Q35934630) (← links)
- Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors (Q36153131) (← links)
- Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation (Q36335121) (← links)
- Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. (Q36344419) (← links)
- The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs (Q36657306) (← links)
- A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms (Q36857533) (← links)
- The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution (Q36993386) (← links)
- Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors (Q37056120) (← links)
- Sequelae and survivorship in patients treated with (131)I-MIBG therapy (Q37081870) (← links)
- Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. (Q37085554) (← links)
- Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis (Q37201458) (← links)
- Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas (Q37274363) (← links)
- Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors (Q37358231) (← links)
- May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate (Q37402627) (← links)
- Early diagnosis and treatment of gastrointestinal neuroendocrine tumors (Q37406973) (← links)
- A woman with metastatic pancreatic neuroendocrine tumor (Q37584857) (← links)
- Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors. (Q37600371) (← links)
- Gastrointestinal neuroendocrine tumors (Q37799954) (← links)
- Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas (Q37815624) (← links)
- Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review (Q37847859) (← links)
- Neuroendocrine Neoplasms of the Gastrointestinal Tract (Q37883066) (← links)
- New therapeutic options for metastatic malignant insulinomas (Q37886036) (← links)
- Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution (Q37918477) (← links)